Schramm, A., Schowe, B., Fielitz, K., Heilmann, M., Martin, M., Marschall, T., . . . Schulte, J. H. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. Nature Publishing Group.
Παραπομπή Chicago StyleSchramm, A., et al. Exon-level Expression Analyses Identify MYCN and NTRK1 As Major Determinants of Alternative Exon Usage and Robustly Predict Primary Neuroblastoma Outcome. Nature Publishing Group, 2012.
Παραπομπή MLASchramm, A., et al. Exon-level Expression Analyses Identify MYCN and NTRK1 As Major Determinants of Alternative Exon Usage and Robustly Predict Primary Neuroblastoma Outcome. Nature Publishing Group, 2012.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.